Sylvie F. Gauthier

Canadian Forest Service
Quebec, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications

Drying Spring Accelerates Transitions Toward Pyrogenic Vegetation in Eastern Boreal North America.

Drying Spring Accelerates Transitions Toward Pyrogenic Vegetation in Eastern Boreal North America.

Journal: Ecology letters
Published: February 04, 2025

Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force.

Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force.

Journal: The journal of prevention of Alzheimer's disease
Published: October 01, 2024

Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.

Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials.

Journal: The journal of prevention of Alzheimer's disease
Published: May 06, 2024

Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer's Disease.

Clinical Correlates of the PET-based Braak Staging Framework in Alzheimer's Disease.

Journal: The journal of prevention of Alzheimer's disease
Published: February 20, 2024

CTAD Task Force Paper: Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force.

CTAD Task Force Paper: Neuropsychiatric Symptoms in AD: Clinical Trials Targeting Mild Behavioral Impairment: A Report from the International CTAD Task Force.

Journal: The journal of prevention of Alzheimer's disease
Published: January 17, 2024

Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer's Disease Continuum.

Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer's Disease Continuum.

Journal: The journal of prevention of Alzheimer's disease
Published: June 25, 2023

Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force.

Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force.

Journal: The journal of prevention of Alzheimer's disease
Published: June 25, 2023

Editorial: Expanding the atn Framework to Further Personalize Therapies.

Editorial: Expanding the atn Framework to Further Personalize Therapies.

Journal: The journal of prevention of Alzheimer's disease
Published: June 25, 2023

White Matter Hyperintensity as a Vascular Contribution to the AT(N) Framework.

White Matter Hyperintensity as a Vascular Contribution to the AT(N) Framework.

Journal: The journal of prevention of Alzheimer's disease
Published: June 25, 2023

Adding the Topographical Information from Tau-PET to the A/T/(N) Framework: Steps Towards Staging AD in Vivo.

Adding the Topographical Information from Tau-PET to the A/T/(N) Framework: Steps Towards Staging AD in Vivo.

Journal: The journal of prevention of Alzheimer's disease
Published: June 25, 2023

Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate.

Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate.

Journal: The journal of prevention of Alzheimer's disease
Published: October 25, 2022

Prediction of Cognitive Decline for Enrichment of Alzheimer's Disease Clinical Trials.

Prediction of Cognitive Decline for Enrichment of Alzheimer's Disease Clinical Trials.

Journal: The journal of prevention of Alzheimer's disease
Published: July 16, 2022
Showing 1-12 of 54

Last Updated: 09/26/2026